USFDA grants Zydus fast track designation for Saroglitazar to treat primary biliary cholangitis
Zydus announced that the United States Food and Drug Administration (USFDA) has granted ‘Fast Track Designation’ to Saroglitazar…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.